Skip to content
Search

Latest Stories

Patients like Pharmacy First, but pharmacies face increased pressure: NPA poll

Patients like Pharmacy First, but pharmacies face increased pressure: NPA poll

Seventy per cent of NPA members indicated being under additional pressure”  after launching the service 

Patients are highly satisfied with the new Pharmacy First service, which enables pharmacists to assess and treat patients for seven common conditions, according to a survey by the National Pharmacy Association (NPA).


Nearly 100 NPA members participated in the snapshot poll conducted at the end of the first full week of the service.

Nine in ten respondents (87 per cent) said that “most or all patients expressed satisfaction” with the service they received.

However, many independent community pharmacy owners are facing challenges in implementing the service.

While 56 per cent of pharmacy owners surveyed expressed feeling “motivated” by the new service, a larger proportion (70 per cent) indicated being “under additional pressure.”

More than 30 per cent of the respondents found implementation of the service “harder” than they had expected.

Twenty per cent reported that their pharmacy had established scheduled windows of time throughout the day for Pharmacy First consultations to ensure the continuity of the essential pharmacy services.

Despite the challenges, 56 per cent of respondents were willing to “offer more NHS advice and treatment” through the service.

Announcing the poll results, Nick Kaye, the Chair of NPA, said that pharmacies in England are already providing significant benefits through Pharmacy First.

“Our poll shows that implementing the service is by no means easy. We commend our members for their efforts and their agility in making this an initial success, despite the challenges of introducing new processes and managing overall workflow in the pharmacy, not to mention the excruciating funding situation,” he said.

NPA members are provided with a comprehensive set of resources to help them implement Pharmacy First.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less